Presented by: Jasmin Choi, PhD, MPH, MSW
Presentation title: Multi-Level Stigma in Outpatient Co-Occurring Disorder Care: Provider Perspectives
Co-occurring mental health and substance use disorders (CODs) affect an estimated 21.5 million adults in the U.S., yet 41% receive no treatment at all. This talk draws on Dr. Choi’s research on outpatient COD care, with a focus on the qualitative analysis of in-depth interviews (n=20) with clinicians and program directors across urban and rural outpatient SUD clinics in New York State. Using a multi-level stigma framework, the talk examines how structural fragmentation, organizational capacity, and clinical risk categorization shape access to comprehensive care, often placing providers between person-centered intent and system-level constraints. Dr. Choi will also reflect on her positionality as a social worker and former substance use counselor conducting this research.
Jasmin Choi is an Assistant Professor in the Department of Population Health at Hofstra University School of Health Sciences. Her research examines how healthcare systems can improve access, engagement, and outcomes for individuals with complex behavioral health needs, particularly those facing high stigma burden. Using mixed methods, administrative data, and implementation-focused approaches, she investigates how organizational, provider, and patient-level factors shape healthcare experiences across behavioral health settings. Dr. Choi brings applied experience in both direct practice and policy to her research. As a licensed social worker, she provided direct counseling and advocacy for underserved communities, including individuals affected by HIV and substance use, as well as immigrant and refugee populations. She later worked as a Federal Policy Analyst for Massachusetts’ Medicaid program, coordinating managed care operations and contributing to state-level health policy initiatives. She has also held research positions at Boston University, Stanford University, and the RAND Corporation.
Presented by: Daniel Bertolino, MPH & Connor Reynolds, MPH
Presentation title: HIV Among People with a History of Injection Drug Use and a Crystal Meth Harm Reduction Program Evaluation – New York City
Daniel Bertolino and Connor Reynolds will provide an overview of recent HIV surveillance data in New York City, focusing on individuals with a history of injection drug use. They will also present an evaluation of a crystal meth harm reduction program in the city.
Daniel Bertolino is the Ending the Epidemic Data Analyst in the Bureau of Hepatitis, HIV, and STIs at the New York City Health Department. He oversees the analysis of citywide HIV surveillance data and the production of annual reports, slide sets, and surveillance statistics tables, as well as the processing of internal and external data requests. He has worked at the NYC Health Department since 2018.
Connor Reynolds is a Data Analyst in the New York City Health Department’s Bureau of Hepatitis, HIV, and STIs, specifically in the HIV Care and Treatment Program’s Research and Evaluation Unit. His primary responsibility is to provide data analysis and reporting to evaluate and plan NYC Tax Levy-funded HIV programs. He has worked at the NYC Health Department since 2022.